Biosimilars And Beyond: Celltrion Aiming For $9bn Post Merger

Two-Phase Plan

 
• By Jung Won Shin
  
merger
Celltrion Group To Begin Merger Of Three Key Affiliates as it aligns pieces • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia